AQSTInvestor Conferencesglobenewswire

Aquestive Therapeutics to Participate in Upcoming September Investor Conferences

Sentiment:Negative (10)

Summary

WARREN, N.J., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science and delivery technologies, announced today that the management team will participate in three upcoming investor conferences in September 2025 as follows:

Original Article

Read the full article from the original source for complete details and context.

Read Full Article

Article published on August 26, 2025 by globenewswire